Quarterly earnings fall 29% as stake in Bank of Communications is diluted

US investment bank acquires firm where former chancellor George Osborne is among five-strong partnership

Equity long-short funds attract investor inflows for first time in a decade on strong returns so far in 2025

Drugmaker struggled to adapt to very high demand and a market where celebrities are more influential than doctors

The word spans too much and clarifies too little

Acquisition would be faster route for fintech to start lending in US than applying for permit of its own

Japan and US issue alerts for coastal areas after 8.8-magnitude temblor

Disgraced financier’s former girlfriend is serving a 20-year prison sentence in Florida

Some Labour MPs and cabinet ministers think the prime minister has been slow to respond to the Gaza crisis

Economic data, corporate earnings and tariff news could set the tone for the remainder of the year

Groups rethink how to keep employees safe after second killing of an executive in Manhattan in less than a year

Repricing activity hits record high of $153bn in July in latest sign of investor optimism

Treasury secretary heads back to Washington after two days of talks with Chinese counterparts

A seminal 1940s study remains hauntingly relevant today

Deal would almost triple valuation of OpenAI’s rival to $170bn

Benjamin Netanyahu accuses Keir Starmer of rewarding Hamas

Israel still not enabling movement of enough food to stave off ‘catastrophic human suffering’, World Food Programme says

Revenue rise comes as drugmaker plans $50bn US investment in face of looming tariff threat

Fund says fall of US currency has helped lessen effect of Donald Trump’s tariffs

Confusion persists over which EU products will be exempt from 15% levy expected to enter into force on Friday

Figures for June show funds were funnelled into savings including Isas

British Retail Consortium warns that expected tax increases in autumn could lift prices further

Share slide wipes more than €60bn off value of Danish maker of Ozempic and Wegovy

Information overload may be contributing to the S&P 500’s resilience